emoxypine succinate has been researched along with dimephosphon in 2 studies
| Studies (emoxypine succinate) | Trials (emoxypine succinate) | Recent Studies (post-2010) (emoxypine succinate) | Studies (dimephosphon) | Trials (dimephosphon) | Recent Studies (post-2010) (dimephosphon) |
|---|---|---|---|---|---|
| 310 | 60 | 130 | 55 | 4 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleyeva, GN; Khafiz'yanova, RKh; Mukhutdinov, DA | 1 |
| Gorbunov, FE; Penionzhkevich, DIu | 1 |
2 other study(ies) available for emoxypine succinate and dimephosphon
| Article | Year |
|---|---|
Lymphotropic effect of dimephosphon, mexidol, and ketorolac is realized via activation of the lymphangion and stimulation of lymph formation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Ketorolac; Lymph; Lymphatic System; Lymphatic Vessels; Organophosphorus Compounds; Picolines; Rats | 2007 |
[New technologies of neurometabolic therapy of cerebrovascular diseases].
Topics: Adult; Aged; Antioxidants; Cerebrovascular Circulation; Cerebrovascular Disorders; Electrophoresis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Organophosphorus Compounds; Picolines; Transcranial Magnetic Stimulation; Treatment Outcome | 2009 |